Messchendorp et al. showed in a previous study that urinary β2M and MCP-1 excretion were both strongly associated with annual GFR decline in ADPKD after statistical adjustment for conventional risk markers [32]. This evidence concerns the gene CCL2 and autosomal dominant polycystic kidney disease.